×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Entity: NLRP3 Inflammasome
entity
1,114 words
KG: NLRP3_INFLAMMASOME
2026-03-22
kind:entity
section:entities
state:published
Contents
NLRP3 Inflammasome
Knowledge Graph
Related Hypotheses (30)
Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming
Score: 0.61
Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-S
Score: 0.60
Dissociating SCFA's Dual Signaling Through GPR43/GPR41 Biase
Score: 0.53
NLRP3/Mitophagy Coupling Modulation
Score: 0.52
Cardiovascular-Neuroinflammation Crosstalk Interruption
Score: 0.44
Microbial Inflammasome Priming Prevention
Score: 0.58
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65
Targeted Butyrate Supplementation for Microglial Phenotype M
Score: 0.56
Purinergic Signaling Polarization Control
Score: 0.55
Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain A
Score: 0.51
P2RX7-Mediated Exosome Secretion Blockade
Score: 0.51
Dual-Phase Medium-Chain Triglyceride Intervention
Score: 0.51
Astrocyte-Microglia Communication Rebalancing via Cytokine M
Score: 0.49
cGAS-STING Senescence Circuit Disruption
Score: 0.49
Microglial Purinergic Reprogramming
Score: 0.48
Metabolic Switch Targeting for A1→A2 Repolarization
Score: 0.48
White Matter Oligodendrocyte Protection via CXCL10 Inhibitio
Score: 0.48
APOE Isoform Expression Across Glial Subtypes
Score: 0.48
Microbiota-Microglia Axis Modulation
Score: 0.48
Acid-Degradable LNP-Mediated Prenatal CRISPR Intervention fo
Score: 0.47
DAMP-Scavenging Microglial Reset
Score: 0.46
Dual-Circuit Tau Vulnerability Cascade with Glial-Mediated A
Score: 0.46
Lysosomal Membrane Repair Enhancement
Score: 0.45
Microbiome-Derived Tryptophan Metabolite Neuroprotection
Score: 0.41
Optogenetic Microglial Deactivation via Engineered Inhibitor
Score: 0.38
TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen
Score: 0.64
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
Score: 0.61
TREM2-Dependent Microglial Senescence Transition
Score: 0.69
Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam
Score: 0.62
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52
Show 25 more
Related Analyses (8)
Lysosomal dysfunction and cathepsin leakage in Alzheimer dis
neuroscience · failed
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
Show 3 more
Related Experiments (16)
Molecular characterization of RBG-NLRP3 binding interaction
exploratory · proposed · Score: 0.90
RBG treatment in ApoE-/- atherosclerosis mouse model
validation · proposed · Score: 0.90
Leukocyte gene expression analysis in COVID-19 patients
exploratory · proposed · Score: 0.90
RBG effects on macrophage polarization and foam cell formati
exploratory · proposed · Score: 0.85
Transcriptomic analysis of RBG effects on inflammatory gene
exploratory · proposed · Score: 0.80
s:** - GPR32 knockout in microglia should worsen neuroinflam
falsification · proposed · Score: 0.40
s:** - Dose-response studies showing therapeutic window with
falsification · proposed · Score: 0.40
Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy
validation · proposed · Score: 0.40
Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.40
Metal Ion Homeostasis Dysregulation in Alzheimer's Disease
validation · proposed · Score: 0.40
Microglial Aging and Immune Memory in Neurodegeneration — Tr
validation · proposed · Score: 0.40
NLRP3 Inflammasome Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40
Tau ASO Therapy
validation · proposed · Score: 0.40
Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.40
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.40
TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.40
Show 11 more
See Also (3)
IL1B Gene - Interleukin 1 Beta
gene · KG edge: produces
IL18 Gene
gene · KG edge: produces
TREM2 Protein (Triggering Receptor Expressed on Myeloid
entity · KG edge: inhibits
Knowledge Graph (3 edges)
NLRP3_INFLAMMASOME
produces
IL1B
NLRP3_INFLAMMASOME
produces
IL18
TREM2
inhibits
NLRP3_INFLAMMASOME